Anthony E Lang

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi Deep brain stimulation: preoperative issues
    Anthony E Lang
    Department of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 21:S171-96. 2006
  2. ncbi Trial designs used to study neuroprotective therapy in Parkinson's disease
    Anthony E Lang
    Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson s Disease, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 28:86-95. 2013
  3. ncbi When and how should treatment be started in Parkinson disease?
    Anthony E Lang
    Toronto Western Hospital, University of Toronto, Canada
    Neurology 72:S39-43. 2009
  4. ncbi Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
    Anthony E Lang
    Toronto Western Hospital, University of Toronto, Ontario, Canada
    Ann Neurol 59:459-66. 2006
  5. ncbi Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough
    Anthony E Lang
    Movement Disorders Clinic, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Lancet Neurol 3:309-16. 2004
  6. ncbi A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials
    Anthony E Lang
    University of Toronto, Toronto, Ontario, Canada
    Mov Disord 26:775-83. 2011
  7. ncbi Psychogenic movement disorders: past developments, current status, and future directions
    Anthony E Lang
    Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 26:1175-86. 2011
  8. ncbi Deep brain stimulation for Parkinson's disease: patient selection and evaluation
    Anthony E Lang
    Division of Neurology, Toronto Western Hospital Movement and University of Toronto, Ontario, Canada
    Mov Disord 17:S94-101. 2002
  9. ncbi Corticobasal degeneration: selected developments
    Anthony E Lang
    Department of Medicine Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 18:S51-6. 2003
  10. ncbi The progression of Parkinson disease: a hypothesis
    Anthony E Lang
    Movement Disorders Centre, Toronto Western Hospital, Toronto, ON, Canada
    Neurology 68:948-52. 2007

Detail Information

Publications107 found, 100 shown here

  1. ncbi Deep brain stimulation: preoperative issues
    Anthony E Lang
    Department of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 21:S171-96. 2006
    ..It outlines answers to a series of questions developed to address all aspects of deep brain stimulation preoperative decision-making...
  2. ncbi Trial designs used to study neuroprotective therapy in Parkinson's disease
    Anthony E Lang
    Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson s Disease, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 28:86-95. 2013
    ..2013 Movement Disorder Society...
  3. ncbi When and how should treatment be started in Parkinson disease?
    Anthony E Lang
    Toronto Western Hospital, University of Toronto, Canada
    Neurology 72:S39-43. 2009
    ..This review will highlight these and other issues that must be considered when deciding on the early treatment of PD...
  4. ncbi Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
    Anthony E Lang
    Toronto Western Hospital, University of Toronto, Ontario, Canada
    Ann Neurol 59:459-66. 2006
    ..This randomized controlled clinical trial was designed to confirm initial clinical benefits observed in a small, open-label trial using intraputamenal (Ipu) infusion of recombinant human GDNF (liatermin)...
  5. ncbi Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough
    Anthony E Lang
    Movement Disorders Clinic, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Lancet Neurol 3:309-16. 2004
    ..Knowledge of the widespread, multisystem nature of the neurodegeneration that accounts for these problems suggests that restoration of the nigrostriatal dopamine system should not be the ultimate goal of future research...
  6. ncbi A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials
    Anthony E Lang
    University of Toronto, Toronto, Ontario, Canada
    Mov Disord 26:775-83. 2011
    ..This article will review the current status of premotor symptoms of Parkinson's disease and discuss their potential for early diagnosis and the design of neuroprotective trials...
  7. ncbi Psychogenic movement disorders: past developments, current status, and future directions
    Anthony E Lang
    Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 26:1175-86. 2011
    ..Given the personal and societal impact of these problems, further advances in our understanding of their pathogenesis and the subsequent development of effective therapies are sorely needed...
  8. ncbi Deep brain stimulation for Parkinson's disease: patient selection and evaluation
    Anthony E Lang
    Division of Neurology, Toronto Western Hospital Movement and University of Toronto, Ontario, Canada
    Mov Disord 17:S94-101. 2002
    ....
  9. ncbi Corticobasal degeneration: selected developments
    Anthony E Lang
    Department of Medicine Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 18:S51-6. 2003
    ..Even if they are eventually found to be distinct disorders, treatments that alter the progression of one may have similar ameliorative effects on the other. Each of these issues are discussed in this selective review of CBD...
  10. ncbi The progression of Parkinson disease: a hypothesis
    Anthony E Lang
    Movement Disorders Centre, Toronto Western Hospital, Toronto, ON, Canada
    Neurology 68:948-52. 2007
    ..This hypothesis has implications for the development of disease-modifying therapy and the interpretation of endpoints of clinical trials evaluating the efficacy of such treatments...
  11. ncbi Stimulation of the subthalamic nucleus and impulsivity: release your horses
    Benedicte Ballanger
    Division of Brain, Imaging and Behaviour Systems Neuroscience, Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
    Ann Neurol 66:817-24. 2009
    ....
  12. ncbi Electrophysiological features of myoclonus-dystonia
    Jie Yuan Li
    Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 23:2055-61. 2008
    ....
  13. ncbi Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease
    Moran Weinberger
    Department of Physiology, Med Sci Building 3302, 1 King's College Circle, University of Toronto, Toronto, Ontario M5S 1A8, Canada
    J Neurophysiol 96:3248-56. 2006
    ..The study also suggests that LFP beta oscillatory activity is generated largely within the dorsal portion of the STN and can produce synchronous oscillatory activity of the local neuronal population...
  14. ncbi Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study
    Benedicte Ballanger
    Toronto Western Research Institute Division of Brain, Imaging and Behaviour Systems Neuroscience, UHN, University of Toronto, Toronto, Ontario, Canada
    Hum Brain Mapp 30:3901-9. 2009
    ..Whether these findings are associated with the DBS-PPN clinical effect remains to be proven. However, they suggest that PPN modulation may induce functional changes in neural networks associated with the control of lower limb movements...
  15. ncbi Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease
    Joyce K H Tang
    Department of Physiology, University of Toronto, Toronto, ON, Canada
    J Neurophysiol 98:720-9. 2007
    ..These findings suggest that alterations in both firing rate and firing pattern may underlie the differing motor symptoms associated with these two movement disorders...
  16. ncbi Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humans
    Jamie Purzner
    The Krembil Neuroscience Centre and Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada M5T 2S8
    J Neurosci 27:6029-36. 2007
    ..The CTC pathway is involved in the preparation of self-paced but not externally cued movements, although the pathway may still be involved in the execution of these movements...
  17. ncbi Involvement of human thalamus in the preparation of self-paced movement
    Guillermo Paradiso
    The Krembil Neuroscience Centre and Toronto Western Research Institute, Toronto, Ontario, Canada
    Brain 127:2717-31. 2004
    ..Different cortico-subcortical circuits may mediate alpha and beta oscillations. During movement preparation, the motor thalamus and the supplementary motor area predominantly interact in the beta band...
  18. ncbi LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation
    Connie Marras
    Movement Disorders Centre, Toronto Western Hospital, Toronto, Canada
    Neurobiol Aging 31:721-2. 2010
    ..In the combined mutation carriers the age at onset and clinical course was highly variable and not always younger than in the carriers of LRRK2 G2019S mutations alone...
  19. ncbi Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons
    Andrew S Lim
    Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Ann Neurol 66:110-4. 2009
    ..This represents the first demonstration that DBS can selectively modulate human sleep, and it supports an important role for the pedunculopontine nucleus region in modulating human REM sleep. Ann Neurol 2009;66:110-114...
  20. ncbi Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
    Connie Marras
    Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 26:608-13. 2011
    ..We suspect that individuals employed full time may have a lower threshold for requiring dopaminergic therapy because of occupational demands...
  21. ncbi Changes in cortical and pallidal oscillatory activity during the execution of a sensory trick in patients with cervical dystonia
    Joyce K H Tang
    Department of Physiology, Med Sci Bldg 3302, 1 King s College Circle, University of Toronto, Toronto, Ontario, Canada M5S 1A8
    Exp Neurol 204:845-8. 2007
    ..These preliminary findings suggest a role for 4-8 Hz frequency synchronization in the pathophysiology of dystonia...
  22. ncbi Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease
    Panida Piboolnurak
    Movement Disorders Center, Division of Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 22:990-7. 2007
    ..1% at 3 years and 19.2% at 5 years). Anti-PD drugs were significantly reduced by 47.9% at 3 years and 39.8% at 5 years. However, the magnitude of the preoperative response to levodopa did not predict DBS benefit at 3 and 5 years...
  23. ncbi Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease
    Elena Moro
    Movement Disorders Centre, Division of Neurology, Department of Medicine, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, ON M5T2S8, Canada
    Brain 134:2096-105. 2011
    ..These findings suggest that unilateral subdural motor cortex stimulation may be useful for contralateral hand tremor in selected patients with essential tremor but was not effective in improving parkinsonian signs in our series...
  24. ncbi Neuronal activity in the globus pallidus of multiple system atrophy patients
    Luiz C M Pereira
    Department of Surgery, Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 19:1485-92. 2004
    ....
  25. ncbi Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: clinical and electrophysiological observations
    Galit Kleiner-Fisman
    Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 19:1209-14. 2004
    ..017, 0.005). There were no side-to-side differences clinically or in the STN neuronal firing rates and patterns. Bilateral STN DBS is safe and efficacious in improving motor symptoms in patients with prior pallidotomy...
  26. ncbi Subdural motor cortex stimulation in Parkinson's disease does not modify movement-related rCBF pattern
    Antonio P Strafella
    Movement Disorders Center, Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 22:2113-6. 2007
    ..We conclude that while MCS may be a simpler and safer surgical procedure than DBS of STN, it failed to provide evidence of clear effect on motor performance and movement-related activation pattern in patients with advanced PD...
  27. ncbi Cortical and spinal abnormalities in psychogenic dystonia
    Alberto J Espay
    Toronto Western Research Institute, University of Toronto, Toronto, Ontario, Canada
    Ann Neurol 59:825-34. 2006
    ..Alternatively, these findings may represent endophenotypic abnormalities that predispose to both types of dystonia...
  28. ncbi The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease
    Renju Kuriakose
    Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada M5T 2S8
    Cereb Cortex 20:1926-36. 2010
    ..Cortical activation may be related to the clinical effects of STN DBS in PD...
  29. ncbi The nonmotor symptoms of Parkinson's disease--an overview
    Shen Yang Lim
    Movement Disorders Centre, Toronto Western Hospital, Ontario, Canada
    Mov Disord 25:S123-30. 2010
    ..The increased focus on these important clinical features represents a major advance in the care of PD patients. In this article, we provide an overview of recent developments in the field...
  30. ncbi Psychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic stimulation
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, UHN, Toronto, Canada
    Adv Neurol 96:130-47. 2005
    ..The paucity of the literature underscores the need for well-designed studies on psychiatric issues investigating both pathophysiology and clinical outcomes...
  31. ncbi Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada
    J Neurosurg 103:246-51. 2005
    ..In the present study, preoperative psychiatric symptoms were systematically assessed in patients with PD presenting for routine preoperative psychiatric assessment...
  32. ncbi Involvement of the cerebellothalamocortical pathway in Parkinson disease
    Zhen Ni
    Division of Neurology, Department of Medicine, University of Toronto and Toronto Western Research Institute, Krembil Neuroscience Centre, University Health Network, Toronto, Ontario, Canada
    Ann Neurol 68:816-24. 2010
    ..We tested whether M1 or cerebellar stimulation can reset PD tremor, and investigated the excitability of the CTC pathway in PD...
  33. ncbi Childhood onset in familial prion disease with a novel mutation in the PRNP gene
    Ekaterina Rogaeva
    Centre for Research in Neurodegenerative Diseases, Department of Medicine, Toronto, Ontario, Canada
    Arch Neurol 63:1016-21. 2006
    ..To our knowledge, the propositus represents the youngest individual with inherited prion disease described to date...
  34. ncbi Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 25:1496-8. 2010
    ..Though sample size was small, there was a trend towards a reduction in LID lasting up to 12 years suggesting that posteroventral pallidotomy may provide sustained benefit in reducing LID...
  35. ncbi Genetic association study of PINK1 coding polymorphisms in Parkinson's disease
    Justus L Groen
    Centre for Research in Neurodegenerative Diseases, Department of Medicine, University of Toronto, 6 Queen s Park Crescent West, Toronto, Ont, Canada M5S 3H2
    Neurosci Lett 372:226-9. 2004
    ..19). Nevertheless, it remains to be evaluated whether PINK1 variations contribute to the risk of common late onset sporadic PD...
  36. ncbi Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias
    Francesca Morgante
    Division of Neurology and Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
    Brain 129:1059-69. 2006
    ..Abnormal synaptic plasticity in the motor cortex may play a role in the development of LID...
  37. ncbi Levodopa-related motor complications--phenomenology
    Susan H Fox
    Division of Neurology, Toronto Western Hospital, Movement Disorders Clinic, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 23:S509-14. 2008
    ..These include fluctuations in FD symptoms termed motor fluctuations, as well as non-motor symptoms, termed non-motor fluctuations. Here we review the phenomenology and methods of assessing these levodopa-related complications...
  38. ncbi Treatment of progressive supranuclear palsy and corticobasal degeneration
    Anthony E Lang
    Toronto Western Hospital, Movement Disorders Clinic, Ontario, Canada
    Mov Disord 20:S83-91. 2005
    ..The similarities in the molecular pathology of these four-repeat tauopathies suggests that important advances in the management of one will have a definite impact on the treatment of the other...
  39. ncbi Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial
    Connie Marras
    Division of Neurology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 23:653-9; quiz 776. 2008
    ..Our focus in clinical care needs to be broadened beyond assessing and treating Parkinsonism, recognizing the impact of mood, cognition and function on HRQOL...
  40. ncbi Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease
    Ekaterina Rogaeva
    Centre for Research in Neurodegenerative Diseases and Division of Neurology, Department of Medicine, Toronto Western Hospital, University of Toronto, Ontario, Canada
    Arch Neurol 61:1898-904. 2004
    ..Mutations in the PTEN-induced kinase (PINK1) gene located within the PARK6 locus on chromosome 1p35-p36 have recently been identified in patients with recessive early-onset Parkinson disease...
  41. ncbi Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release
    Aviva Abosch
    Department of Surgery, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, and University Health Network, University of Toronto, Toronto, Ontario, Canada
    Neurosurgery 53:1095-102; discussion 1102-5. 2003
    ..We sought to determine whether STN stimulation could release endogenous striatal dopamine...
  42. ncbi Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study
    Alberto J Espay
    Toronto Western Research Institute, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 24:1001-8. 2009
    ..Levodopa, however, normalized speed to a greater extent than amplitude. Our observations suggest that amplitude and speed impairments may be associated with different functional aspects in PD and deserve separate clinical assessment...
  43. ncbi Overview of the extranigral aspects of Parkinson disease
    Shen Yang Lim
    Movement Disorders Centre, Toronto Western Hospital, 399 Bathurst St, Toronto, Ontario M5T 2S8, Canada
    Arch Neurol 66:167-72. 2009
    ..Later-stage features often contribute markedly to disability and impaired quality of life and, therefore, represent an important future therapeutic challenge...
  44. ncbi Subthalamic nucleus stimulation: improvements in outcome with reprogramming
    Elena Moro
    Movement Disorders Center and Department of Neurosurgery, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario
    Arch Neurol 63:1266-72. 2006
    ..Even when the electrode is well positioned in the target, the optimization of clinical results depends on careful programming of electrical parameters and changes in antiparkinsonian drug dosages...
  45. ncbi rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET study
    Antonio P Strafella
    Movement Disorders Center, Toronto Western Hospital, Division of Neurology, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 23:1051-4. 2008
    ....
  46. ncbi Is there seasonal variation in risk of Parkinson's disease?
    Ronald B Postuma
    Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada
    Mov Disord 22:1097-101. 2007
    ..We found no evidence of systematic seasonal variation in PD incidence by birth date, or of clustering of birth dates during influenza pandemic years in PD patients...
  47. ncbi Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease
    Adrian P Fawcett
    Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 20:371-7. 2005
    ..Our data demonstrate a task-specific improvement of oculomotor deficits in this HD patient with pallidal DBS, supporting a role of GPi in oculomotor control...
  48. ncbi Bilateral globus pallidus stimulation for Huntington's disease
    Elena Moro
    Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario, Canada
    Ann Neurol 56:290-4. 2004
    ..Adjustment of stimulation parameters in GPi DBS may have the potential to optimize the motor response in HD, improving chorea without aggravating bradykinesia...
  49. ncbi Motor cortical stimulation for parkinsonism in multiple system atrophy
    Galit Kleiner-Fisman
    Division of Neurology and Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Ontario
    Arch Neurol 60:1554-8. 2003
    ..CONCLUSIONS: Our data suggest that motor cortical stimulation using these parameters fails to improve the motor disability in MSA. Worsening of motor scores was likely a function of disease progression...
  50. ncbi Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients
    Joyce K H Tang
    Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, M5S 1A8
    Exp Brain Res 166:230-6. 2005
    ..Furthermore, the findings did reveal a difference between firing patterns in the HD and PD groups, thereby supporting the role of altered firing patterns in the pathophysiology of these diseases...
  51. ncbi Caffeine for treatment of Parkinson disease: a randomized controlled trial
    Ronald B Postuma
    Department of Neurology, McGill University, Montreal General Hospital, Montreal, Canada
    Neurology 79:651-8. 2012
    ..Epidemiologic studies consistently link caffeine, a nonselective adenosine antagonist, to lower risk of Parkinson disease (PD). However, the symptomatic effects of caffeine in PD have not been adequately evaluated...
  52. ncbi Reduced intracortical and interhemispheric inhibitions in corticobasal syndrome
    Pramod Kr Pal
    Division of Neurology and Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
    J Clin Neurophysiol 25:304-12. 2008
    ..In conclusion, CBS patients had deficits in intracortical and interhemispheric inhibition in the representations for both distal and proximal upper limb muscles bilaterally with relative sparing of motor cortical output pathways...
  53. ncbi Non-dopaminergic treatments in development for Parkinson's disease
    Susan H Fox
    Movement Disorders Clinic, Division of Neurology, University of Toronto, Toronto, ON, Canada
    Lancet Neurol 7:927-38. 2008
    ..Here, we review novel non-dopaminergic approaches that are in at least phase II clinical development for the treatment of PD...
  54. ncbi Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?
    Thilo van Eimeren
    Division of Brain, Imaging and Behaviour Systems Neuroscience, BIB SN, Toronto Western Research Institute, University of Toronto, Toronto, ON, Canada
    Neuropsychopharmacology 34:2758-66. 2009
    ..Our findings raise the question of whether pathological gambling may in part stem from an impaired capacity of the OFC to guide behavior when facing negative consequences...
  55. ncbi Orthostatic tremor in progressive supranuclear palsy
    Rob M A De Bie
    Movement Disorders Center, Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 22:1192-4. 2007
    ..quot; We describe a patient with OT, with postural tremor of the arms and restless legs syndrome (RLS), who developed features typical of progressive supranuclear palsy (PSP). PSP can be accompanied by OT...
  56. ncbi Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man
    Galit Kleiner-Fisman
    Department of Medicine, Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 19:534-43. 2004
  57. ncbi Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
    Ronald B Postuma
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Ontario, Canada
    Neurology 63:886-91. 2004
    ..At present, no controlled prospective studies have evaluated this phenomenon, although they are ongoing...
  58. ncbi Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: differential effects on bradykinesia
    Asha Kishore
    Division of Neurology, Department of Medicine, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 22:328-33. 2007
    ..This observation also highlights the need to perform tasks of bradykinesia in one limb at a time for best accuracy...
  59. ncbi Extrastriatal dopaminergic dysfunction in tourette syndrome
    Thomas D L Steeves
    Division of Neurology, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada
    Ann Neurol 67:170-81. 2010
    ..A substantial body of evidence has also accrued to implicate regions outside the striatum in the generation of tics...
  60. ncbi Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging
    Jean A Saint-Cyr
    Department of Surgery, Division of Neurosurgery, University of Toronto and University Health Network, Toronto, Ontario, Canada
    J Neurosurg 97:1152-66. 2002
    ..The authors sought to determine the location of deep brain stimulation (DBS) electrodes that were most effective in treating Parkinson disease (PD)...
  61. ncbi Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patients
    Cindy Zadikoff
    Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 21:875-9. 2006
    ..We describe two unrelated cases with PINK1 mutations (homozygous nonsense and heterozygous missense) that highlight issues regarding the role of heterozygous mutations and the utility of genetic screening in patient care...
  62. ncbi Analysis of the glucocerebrosidase gene in Parkinson's disease
    Christine Sato
    Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 20:367-70. 2005
    ..Our results demonstrate a marginally significant association of GBA mutations with PD and suggest that variations in the GBA gene may constitute a rare susceptibility factor for PD (P = 0.048)...
  63. ncbi Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor
    Rajeev Kumar
    Division of Neurology, Faculty of Medicine, University of Toronto, Canada
    Neurology 61:1601-4. 2003
    ..Two of five patients with essential tremor had contralateral tremor improvement after ongoing stimulation for 2 years; two developed marked tolerance to DBS...
  64. ncbi Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease
    Galit Kleiner-Fisman
    Division of Neurology and Neurosurgery, Toronto Western Hospital, University of Toronto, Ontario, Canada
    J Neurosurg 99:489-95. 2003
    ..Improvements in tremor, rigidity, and bradykinesia were more marked and better sustained over time than improvements in axial symptoms. A good preoperative response to levodopa predicted a good response to surgery...
  65. ncbi Characterization of REM-sleep associated ponto-geniculo-occipital waves in the human pons
    Andrew S Lim
    Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada
    Sleep 30:823-7. 2007
    ..We sought to identify and characterize human PGO waves...
  66. ncbi Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation
    Hazem A Eltahawy
    Division of Neurosurgery, Toronto Western Hospital, Toronto, Ontario, Canada
    Neurosurgery 54:613-19; discussion 619-21. 2004
    ..The presence of basal ganglia abnormalities on the preoperative magnetic resonance imaging scan is an indicator of a lesser response to pallidal interventions for dystonia...
  67. ncbi Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
    Elena Moro
    Toronto Western Hospital, Movement Disorders Center, University of Toronto and University Health Network, Toronto, Ontario, Canada
    Mov Disord 25:578-86. 2010
    ..Although the surgical targets were not randomized, there was a trend to a better outcome of motor signs in the STN-DBS patients and fewer adverse events in the GPi-DBS group...
  68. ncbi Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease
    Ron Levy
    Department of Physiology, University of Toronto, Toronto, Canada
    Brain 125:1196-209. 2002
    ....
  69. ncbi Neonatal ablation of the nigrostriatal dopamine pathway does not influence limb development in rats
    Matthew O Hebb
    Division of Neurosurgery, University of Toronto, Toronto, Ontario, M5T 2S8, Canada
    Exp Neurol 177:547-56. 2002
    ..The results of this study indicate that early skeletal development in rats is not affected by loss of nigrostriatal dopamine per se, but is markedly attenuated by corticospinal lesions sustained during the neonatal period...
  70. ncbi Myoclonus in parkinsonian disorders
    Mohamed Shafiq
    Department of Medicine (Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
    Adv Neurol 89:77-83. 2002
  71. ncbi Translational research in neurology and neuroscience 2011: movement disorders
    Christine Klein
    Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Lubeck, Lubeck, Germany
    Arch Neurol 68:709-16. 2011
    ..Aetiology and pathogenesis, biomarker directions, and causal treatment opportunities are discussed for each disease, followed by a brief discussion drawing attention to important translational initiatives...
  72. ncbi Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study
    Taresa Stefurak
    Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 18:1508-16. 2003
    ....
  73. ncbi Pallidal neuronal activity: implications for models of dystonia
    William D Hutchison
    Department of Surgery, Division of Neurosurgery and Toronto Western Research Institute, Toronto Western Hospital and Faculty of Medicine, University of Toronto, Ontario, Canada
    Ann Neurol 53:480-8. 2003
    ..The widely accepted pathophysiological models of dystonia that propose global decreases in basal ganglia output need to be viewed with caution in light of these findings...
  74. ncbi Tongue control for swallowing in Parkinson's disease: effects of age, rate, and stimulus consistency
    Pascal H H M van Lieshout
    Department of Speech Language Pathology, University of Toronto, and Toronto Western Hospital Research Institute, University Health Network, Toronto, Ontario, Canada
    Mov Disord 26:1725-9. 2011
    ..Efficient swallows require well-coordinated tongue movements during bolus flow, but little is known about such movements in Parkinson's disease...
  75. ncbi A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
    Connie Marras
    Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 24:2370-8. 2009
    ..This may relate to changes in philosophies with respect to starting treatment for Parkinson's disease, but the factors underlying this change remain to be elucidated...
  76. ncbi Punding prevalence in Parkinson's disease
    Janis M Miyasaki
    Movement Disorders Centre, Toronto Western Hospital, University Health Network, Krembil Neuroscience Centre, University of Toronto, Toronto, Canada
    Mov Disord 22:1179-81. 2007
    ..4%) in contrast with previous reports of 14%. Despite the low incidence, this behavior is disruptive and should be carefully elicited by physicians caring for Parkinson's disease patients...
  77. ncbi Antipsychotic use in older adults with Parkinson's disease
    Connie Marras
    Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, University Health Network, Toronto, Canada
    Mov Disord 22:319-23. 2007
    ..Typical antipsychotics are still commonly being chosen as first-line agents for older patients, indicating a need for interventions to improve practice...
  78. ncbi Does severity of Parkinson's disease vary according to season?
    Ronald B Postuma
    Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada
    Mov Disord 20:476-9. 2005
    ..We found no evidence for seasonal fluctuation in the UPDRS scores, suggesting that, although considerable day-to-day variation may exist in PD, there is little monthly or seasonal variation...
  79. ncbi Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease
    Valerie Voon
    University of Toronto, Toronto Western Hospital University Health Network, Ontario, Canada
    Clin Neuropharmacol 27:90-2. 2004
    ..Potential mechanisms implicated in the response of psychosis to antidepressants are discussed...
  80. ncbi Clinical findings in a large family with a parkin ex3delta40 mutation
    Renato P Munhoz
    Movement Disorders Centre, Toronto Western Hospital, and Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada
    Arch Neurol 61:701-4. 2004
    ..CONCLUSION: In families with a dominant inheritance, an additional genetic or environmental cause must coexist with the Ex3Delta40 mutation...
  81. ncbi Progress in clinical neurosciences: a forum on the early management of Parkinson's disease
    Anthony E Lang
    Division of Neurology, Department of Medicine, University of Toronto, Toronto Western Hospital, Canada
    Can J Neurol Sci 32:277-86. 2005
    ..This report summarizes presentations and discussion dealing with these issues from a one-day symposium involving Canadian Movement Disorders neurologists...
  82. ncbi Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike?
    Anthony E Lang
    Movement Disorders Centre, Toronto Western Hospital, Toronto, Canada
    Mov Disord 18:351-2; author reply 352. 2003
  83. ncbi Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
    Yun J Kim
    Morton and Gloria Shulman Movement Disorders Center and the Division of Neurology (Department of Medicine, The Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 17:303-12. 2002
    ..These findings suggest that DAT SPECT may be useful in differentiating parkinsonism from controls and D2 SPECT in further differentiating MSA from Parkinson's disease and possibly PSP...
  84. ncbi Subthalamic stimulation for Parkinson's disease--living better electrically?
    Anthony E Lang
    University of Toronto, Toronto
    N Engl J Med 349:1888-91. 2003
  85. ncbi Apraxia in movement disorders
    Cindy Zadikoff
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Brain 128:1480-97. 2005
    ..Finally, although apraxia results in clear disability in patients with the CBS, it is not clear how milder ideomotor apraxia found on specific testing contributes to patients' overall day-to-day motor disability...
  86. ncbi Neurodegenerative disease and the evolution of art: the effects of presumed corticobasal degeneration in a professional artist
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Division of Neurology, The Toronto Hospital, University of Toronto, Western Division, 399 Bathurst Street, MP11-306, Toronto, Ontario M5T 2S8, Canada
    Mov Disord 18:294-302. 2003
    ..Our case study adds to the growing literature on the effects of brain damage on artistic expression in the graphic arts...
  87. ncbi Large deletions account for an increasing number of mutations in SGCE
    Fabin Han
    Ottawa Health Research Institute, Ottawa, Ontario, Canada
    Mov Disord 23:456-60. 2008
    ..This is only the second report of intragenic deletions with SGCE and it highlights the need to include exonic copy number variation when performing mutational analysis of SGCE...
  88. ncbi Criteria for deep-brain stimulation in Parkinson's disease: review and analysis
    Elena Moro
    University of Toronto, Department of Medicine, Movement Disorders Center, 399 Bathurst Street, McL7 402, Canada
    Expert Rev Neurother 6:1695-705. 2006
    ..The recent observation that deep-brain stimulation of the pedunculopontine nucleus improves axial signs, possibly even in those less responsive to levodopa, brings new hope to the management of advanced Parkinson's disease...
  89. ncbi Rapidly progressive sporadic dentatorubral pallidoluysian atrophy with intracytoplasmic inclusions and no CAG repeat expansion
    Alberto J Espay
    Toronto Western Research Institute, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 21:2251-4. 2006
    ..This case expands the clinical and neuropathological spectrum of DRPLA and supports the hypothesis that aggregates may not be intrinsically pathogenic...
  90. ncbi Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
    Claire Ardouin
    , CHU Grenoble, INSERM U318, , Grenoble, France
    Mov Disord 21:1941-6. 2006
    ....
  91. ncbi Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes
    Galit Kleiner-Fisman
    Parkinson s Disease Research Education and Clinical Center, Philadelphia VA Hospital, Philadelphia, Pennsylvania 19104, USA
    Mov Disord 21:S290-304. 2006
    ..These data provide an estimate of the magnitude of the treatment effects and emphasize the need for controlled and randomized studies...
  92. ncbi Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group
    Douglas E Hobson
    Department of Medicine, University of Maitoba, Winnipeg
    JAMA 287:455-63. 2002
    ..The frequency of these spells and whether driving should be restricted has yet to be established...
  93. ncbi Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations
    Deborah Raymond
    The Alan and Barbara Mirken Department of Neurology, Beth Israel Medical Center, New York, New York 10003, USA
    Mov Disord 23:588-92. 2008
    ..0097). We found no association between mutation type and phenotype...
  94. ncbi Antidepressants and psychosis in Parkinson disease: a case series
    Valerie Voon
    Int J Geriatr Psychiatry 22:601-4. 2007
  95. ncbi Sporadic case of dentatorubral pallidoluysian atrophy with no CAG repeat expansion and no intranuclear inclusions
    Renato P Munhoz
    Movement Disorders Centre, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 19:580-3. 2004
    ..Family history and genetic testing were unrevealing. Neuropathological findings were identical to genetic dentatorubral pallidoluysian (DRPLA) except for the lack of intranuclear inclusions...
  96. ncbi Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
    Michael A Schwarzschild
    MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, USA
    Arch Neurol 65:716-23. 2008
    ..To determine whether concentration of serum urate, a purine metabolite and potent antioxidant that has been linked to a reduced risk of Parkinson disease (PD), predicts prognosis in PD...
  97. ncbi Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
    Daniel G Healy
    Department of Clinical Neurosciences, Institute of Neurology, University College London, London, UK
    Lancet Neurol 7:583-90. 2008
    ..LRRK2-associated PD be distinguished from idiopathic PD; which mutations in LRRK2 are pathogenic; and what is the age-specific cumulative risk of PD for individuals who inherit or are at risk of inheriting a deleterious mutation in LRRK2?..
  98. ncbi A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
    Cindy Zadikoff
    Department of Neurology, Northwestern University, Parkinson s Disease and Movement Disorders Center, Chicago, Illinois, USA
    Mov Disord 23:297-9. 2008
    ..000002). Compared to the MMSE, the MoCA may be a more sensitive tool to identify early cognitive impairment in PD...
  99. ncbi Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
    Robert A Hauser
    Parkinson s Disease and Movement Disorders Center, University of South Florida, Tampa, Florida 33606, USA
    Mov Disord 22:2409-17. 2007
    ..Early treatment decisions for individual patients depend largely on the anticipated risk of side effects and long-term complications. Both ropinirole and levodopa are viable treatment options in early PD...
  100. ncbi Sustained relief of dystonia following cessation of deep brain stimulation
    Matthew O Hebb
    Division of Neurosurgery, Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
    Mov Disord 22:1958-62. 2007
    ....
  101. ncbi Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease
    Anthony E Lang
    Ann Neurol 55:761-5. 2004